-transparent.png){kind=logo}
A myasthenic reaction developed after an average latency of seven to eight months in 12 female patients (average age 51 years) treated with penicillamine for chronic rheumatoid arthritis. In most of them only the purely ocular form was noted, but generalisation of various degrees also occurred. When penicillamine had been discontinued the myasthenic signs were almost always fully reversible, recurring once again when treatment with penicillamine was started. In some instances a transitory symptomatic treatment with cholinesterase inhibitors was necessary. The occurrence of the myasthenic signs in these circumstances is probably similar to the anti-basal membrane nephropathy induced by penicillamine.
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
December 1975,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
September 1990,
Journal of clinical neuro-ophthalmology,
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
November 1977,
Annals of internal medicine,
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
January 1979,
The Journal of rheumatology,
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
May 1981,
La Nouvelle presse medicale,
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
May 1981,
Ryumachi. [Rheumatism],
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
June 1980,
Ryumachi. [Rheumatism],
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
February 1977,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
October 1983,
Annals of the rheumatic diseases,
D Seitz, and
H C Hopf, and
R W Janzen, and
W Meyer
June 1991,
Ryumachi. [Rheumatism],
